Best Practices in Global Pharmaceutical Launches
Discover how the world's leading pharmaceutical companies develop global launch strategies, manage launch teams, cultivate thought leader support, integrate marketing activities, and conduct a host of other critical launch activities.
Sales and Marketing > New Product Development and Launch d
Industries Profiled:
Pharmaceutical; Health Care; Biotech; Medical Device
Companies Profiled:
Merck; Sanofi-aventis; Eli Lilly; Wyeth; GlaxoSmithKline ; Novartis; Pfizer; Johnson & Johnson; Bristol-Myers Squibb; AstraZeneca; Roche; Schering-Plough
Study Snapshot
This Best Practices Benchmarking® Report identifies the winning strategies, practices and investment patterns that distinguish successful global marketing launches. These project findings are designed to enable you and your team to move knowledgeably forward toward the objective of developing your own world-class marketing launch capabilities.
The report includes:
- Analysis of the multi-year marketing launch investment and expense patterns of successful products.
- Profiles of leading pharmaceutical companies’ approaches to structuring global marketing organization.
- Identification of best management practices employed during key launch activities.
- Key Lessons Learned in planning and coordinating successful global product launches.
The leading practices, managerial insights and benchmark metrics in this report are drawn from in-depth surveys and lessons learned interviews with more than 26 executives at several leading pharmaceutical companies. The project team, composed of seasoned experts and analysts at Best Practices, LLC, probed 12 product launches in-depth.
Companies Interviewed/Surveyed | Product Launches Analyzed |
- Merck
- Eli Lilly
- Pfizer
- GlaxoSmithKline
- Wyeth
- Novartis
- Johnson & Johnson
- Bristol-Myers Squibb
- Sanofi-Aventis
- Roche
- Schering-Plough
- AstraZeneca
|
- Cozaar
- Fosamax
- Zyprexa
- Lescol
- Lipitor
- Xalatan
- Imitrex / Imigran
- Zoloft
- Ceftin
- Paxil
- Cardizem
- Zofran
|
Additionally, pharmaceutical product launch information was gathered from various other sources, including Best Practices, LLC’s own proprietary databases, other public and private databases, literature reviews, and on-line data research.
Back to Top
Key Findings
Benchmark study findings are organized into an executive summary and two parts:
Executive Summary – The executive summary outlines the five top "Lessons Learned," as identified by benchmark partners and Best Practices, LLC project analysts. Studying these lessons learned will help benchmark partners frame their overall thinking about global marketing launch decisions. Accompanying charts provide one-glance summaries of the key learnings of the project.
Survey Data Analysis – Based on benchmark partners’ survey responses, this section analyzes investment patterns, activity timing and organizational structure for global marketing launches. It also identifies key launch activities that have the greatest impact on product success. This section contains seven sub-sections: Benchmark Methodologies, Survey Data Overview, Thought Leader Development, Sales Force Support, Marketing Activities, Market Research, and Life Cycle Management.
Interview Analysis – Lessons Learned, Best Practices and Key Trends: Part II addresses critical strategic learnings identified by benchmark partners. It is divided into seven sub-sections: Global Marketing Launch Strategy and Structure, Managing Cross-Functional Teams, Thought Leader Development, Sales Force Support, Market Research, Marketing Activities, and Life Cycle Management.
Back to Top
Related Research:
R&D Quality Assurance Excellence Library
 |
A must-have for all pharmaceutical, biotech and medical device manufacturing executives, this Best Practices' R&D Quality Assurance bundle tells you everything you need to know about quality... (ID OPS-95)
Companies Profiled: aaiPharma, Sanofi-aventis, Abbott, Abbott Laboratories, more ...
Price: $21100.00 Free Excerpt Available
| |
Best Practices in Global Pharmaceutical Launches
 |
Discover how the world's leading pharmaceutical companies develop global launch strategies, manage launch teams, cultivate thought leader support, integrate marketing activities, and conduct a host of other critical launch activities... (ID SM-120)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, Wyeth, more ...
Price: $7000.00 Free Excerpt Available
| |
|